Replies to post #15500 on Pluristem Therapeutics Inc (PSTI)

[zzaatt]

And think about it... Truth be told,
This indication, at the time of trial design was PSTI's highest opportunity of success. Higher than any other possible indications based on the MOA (mechanism of action) - mesenchymal stem cell activity, healing and regenerating - the 'promise' of stem cell treatment. CLI has the Highest chance of success for this MOA to demonstrate its most statistically significant effects. Literally, angiogenesis and vasculogenesis … growing new tissue, vessels, capillaries, in essence, re-birthing tissues, vasculature and limbs.

Could you rephrase that, I can't extract any coherent point! My best guess is that it's something to do with the P3 for CLI.